$46 Million is the total value of Telemetry Investments, L.L.C.'s 73 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VAR | New | VARIAN MED SYS INC | $1,772,000 | – | 10,300 | +100.0% | 3.85% | – |
| HGEN | New | HUMANIGEN INC | $1,507,000 | – | 141,676 | +100.0% | 3.27% | – |
| LVGO | New | LIVONGO HEALTH INC | $1,036,000 | – | 7,400 | +100.0% | 2.25% | – |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $971,000 | – | 18,500 | +100.0% | 2.11% | – |
| MXIM | New | MAXIM INTEGRATED PRODS INC | $817,000 | – | 12,078 | +100.0% | 1.78% | – |
| IMMU | New | IMMUNOMEDICS INC | $611,000 | – | 7,191 | +100.0% | 1.33% | – |
| AIMT | New | AIMMUNE THERAPEUTICS INC | $534,000 | – | 15,500 | +100.0% | 1.16% | – |
| RST | New | ROSETTA STONE INC | $470,000 | – | 15,662 | +100.0% | 1.02% | – |
| PCG | New | PG&E CORP | $446,000 | – | 47,500 | +100.0% | 0.97% | – |
| VRTU | New | VIRTUSA CORP | $270,000 | – | 5,500 | +100.0% | 0.59% | – |
| BMY | New | BRISTOL-MYERS SQUIBB CO | $229,000 | – | 3,800 | +100.0% | 0.50% | – |
| FE | New | FIRSTENERGY CORP | $218,000 | – | 7,600 | +100.0% | 0.47% | – |
| AEM | New | AGNICO EAGLE MINES LTD | $215,000 | – | 2,700 | +100.0% | 0.47% | – |
| BREW | New | CRAFT BREW ALLIANCE INC | $190,000 | – | 11,500 | +100.0% | 0.41% | – |
| VCNX | New | VACCINEX INC | $104,000 | – | 58,300 | +100.0% | 0.23% | – |
| VERU | New | VERU INC | $79,000 | – | 30,093 | +100.0% | 0.17% | – |
| HUD | New | HUDSON LTD | $76,000 | – | 10,000 | +100.0% | 0.16% | – |
| INWK | New | INNERWORKINGS INC | $42,000 | – | 14,000 | +100.0% | 0.09% | – |
| ONDK | New | ON DECK CAP INC | $41,000 | – | 25,500 | +100.0% | 0.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RIGEL PHARMACEUTICALS INC | 33 | Q4 2022 | 1.7% |
| AFFIMED N V | 31 | Q4 2022 | 3.9% |
| GLOBALSTAR INC | 30 | Q4 2022 | 2.5% |
| VIEWRAY INC | 23 | Q4 2022 | 2.1% |
| SPDR GOLD TRUST | 22 | Q4 2022 | 2.3% |
| ADMA BIOLOGICS INC | 21 | Q4 2022 | 2.9% |
| STEMLINE THERAPEUTICS INC | 21 | Q1 2020 | 1.2% |
| SPDR S&P 500 ETF TR | 20 | Q4 2022 | 53.9% |
| KADMON HLDGS INC | 19 | Q2 2021 | 7.0% |
| EIGER BIOPHARMACEUTICALS INC | 19 | Q4 2022 | 6.7% |
View Telemetry Investments, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Xtant Medical Holdings, Inc. | February 13, 2020 | 752,915 | 5.7% |
| Orexigen Therapeutics, Inc. | February 14, 2019 | 1,295,844 | 6.4% |
| Xtant Medical Holdings, Inc. | February 14, 2018 | 1,416,339 | 7.2% |
View Telemetry Investments, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-17 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
View Telemetry Investments, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.